Stock THAR THARIMMUNE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Tharimmune, Inc.

Equities

THAR

US4327053090

Market Closed - Nasdaq
Other stock markets
 21:00:00 21/06/2024 BST 		5-day change 1st Jan Change
2.82 USD -9.90% Intraday chart for Tharimmune, Inc. -15.82% -63.06%
06-20 Tharimmune Prices $2.1 Million Private Placement of Common Shares, Warrants MT
06-18 Tharimmune, Inc. announced that it expects to receive $2.084162 million in funding from GRAVITAS Capital Advisors, Inc., SDS Capital Group and other investors CI

Evolution of the average Target Price on Tharimmune, Inc.

Price target over the last 5 years

History of analyst recommendation changes

a4f6dc312efc4f21c800.cysmorhLJVeuAcDQP3yrFVkNuB3PV1ehbaNTI-mnsrg.QkJSkdAeSTHoZ7C3bTCYVx1P73maHnrUNPpmZpOS_9orfWva4BppevhCiQ~866dc911e87eea5d769fc24a40f1564a

Analyst Recommendations on Tharimmune, Inc.

Dawson James Downgrades Hillstream BioPharma to Neutral From Buy MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
2.82 USD
Average target price
75 USD
Spread / Average Target
+2,559.57%
High Price Target
75 USD
Spread / Highest target
+2,559.57%
Low Price Target
75 USD
Spread / Lowest Target
+2,559.57%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Tharimmune, Inc.

Dawson James

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. THAR Stock
  4. Consensus Tharimmune, Inc.